These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1758135)
1. [Therapy of acute myeloid leukemia in children--results of the AML II/87 multicenter study]. Hermann J; Zintl F; Krause M; Palme H; Fuchs D; Prager J; Dörffel W; Domula M; Eggers G; Exadaktylos P Kinderarztl Prax; 1991 Nov; 59(11):321-7. PubMed ID: 1758135 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165 [TBL] [Abstract][Full Text] [Related]
3. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]. Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115 [TBL] [Abstract][Full Text] [Related]
4. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children]. Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274 [TBL] [Abstract][Full Text] [Related]
5. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation. Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F; Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930 [TBL] [Abstract][Full Text] [Related]
6. [Results of allogenic and autologous bone marrow transplantation in children with acute myeloid leukemia]. Hermann J; Fuchs D; Prager J; Palme H; Müller A; Füller J; Vogelsang H; Zintl F Kinderarztl Prax; 1992 Apr; 60(2):35-9. PubMed ID: 1608183 [TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report. Berger M; Ferrero I; Vassallo E; Gastaldo L; Carraro F; Biasin E; Madon E; Fagioli F Pediatr Hematol Oncol; 2005; 22(7):597-608. PubMed ID: 16166053 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [TBL] [Abstract][Full Text] [Related]
9. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G; J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428 [TBL] [Abstract][Full Text] [Related]
10. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group. Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490 [TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy. Meloni G; De Fabritiis P; Carella AM; Mangoni L; Porcellini A; Marmont A; Mandelli F Bone Marrow Transplant; 1990 Jan; 5(1):29-32. PubMed ID: 2404528 [TBL] [Abstract][Full Text] [Related]
12. BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. Meloni G; Vignetti M; Avvisati G; Capria S; Micozzi A; Giona F; Mandelli F Bone Marrow Transplant; 1996 Oct; 18(4):693-8. PubMed ID: 8899182 [TBL] [Abstract][Full Text] [Related]
14. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update. Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292 [TBL] [Abstract][Full Text] [Related]
16. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group. Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A; J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036 [TBL] [Abstract][Full Text] [Related]
17. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [TBL] [Abstract][Full Text] [Related]
19. [Current results of cooperative AML therapy studies in children: BFM-78 and 83]. Creutzig U; Ritter J; Budde M; Riehm H; Henze G; Lampert F; Gerein V; Müller-Weihrich S; Niethammer D; Spaar HJ Klin Padiatr; 1986; 198(3):183-90. PubMed ID: 3523024 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group. Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909 [No Abstract] [Full Text] [Related] [Next] [New Search]